13 Patents
- US126126322026Compositions for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic Cells
Toolgen Incorporated
0 cites - US126126342026Compositions for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic Cells
TOOLGEN INCORPORATED
0 cites - US126126332026Compositions for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic Cells
Toolgen Incorporated
0 cites - US126068322026Compositions for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic Cells
Toolgen Incorporated
0 cites - 0 cites
- US125402972026Microfluidic Device for Cerebrovascular Simulation and High-efficiency Blood-brain Barrier Simulation System Comprising Same
CELLARTGEN Inc.
0 cites - US125347042026Organ Extracellular Matrix-derived Scaffold for Culture and Transplantation of Organoid and Method of Preparing the Same
CELLARTGEN Inc.
0 cites - US124735592025Cas9/rna Complexes for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic Cells
Toolgen Incorporated
0 cites - US122216392025Allulose Epimerase Variant with Excellent Thermal Stability, Preparation Method Therefor, and Preparation Method for Allulose Using Same
DAESANG CORPORATION
0 cites - 0 cites
- 0 cites
- US116347402023Allulose Epimerase Variant, Method for Preparing the Same, and Method for Preparing Allulose Using the Same
DAESANG CORPORATION
0 cites - 0 cites